20-22 August 2018

San Francisco, CA

Category:


Adalta Fibrosis Symposium

Delivering independent investment research to investors on Australian biotech, pharma and healthcare companies

by charrison | July 21, 2017 | posted in | No Comments


An Interview with James A. Cardelli

by oliviab | July 13, 2017 | posted in | No Comments


Idiopathic Pulmonary Fibrosis

AdAlta White Paper

by charrison | July 21, 2017 | posted in | No Comments


IPF Full Event Brochure 2018

Take a look at the complete agenda and speaker line-up of 18 industry experts. “All the speakers were superb, and every session provided novel and important insight regarding IPF. The effort the speakers put into their presentations was evident. Great job!” Ceders-Sinai Medical Center

by Ridhi | April 9, 2018 | posted in | No Comments


Biomarkers & Mechanistic Insights from Clinical Studies of Pirfenidone

By Joe Arron, Senior Director, Immunology Research, Genentech  

by lydiac | June 20, 2018 | posted in | No Comments


Utilizing Patient Derived Systems to Advance Drug Discovery in IPF

By Jeremy Duffield, Global Head of Human Biology, Vertex Pharmaceuticals

by lydiac | May 24, 2018 | posted in | No Comments